Dear Colleagues,

Welcome to the Best of ASCO 2025 in Qatar! We are pleased to invite you to an event themed "The ASCO Experience in Qatar: Integrating Discovery into Practice for Better Cancer Care," a distinguished gathering hosted by Hamad Medical Corporation (HMC), the Best of the American Society of Clinical Oncology (ASCO) 2025 is globally recognized for its leadership in cancer research and education, and this conference serves as a crucial platform for sharing significant studies and exploring the latest advancements in cancer treatment and management.

The Best of ASCO program offers healthcare professionals worldwide a unique opportunity to access key highlights from the leading ASCO conference, specifically tailored to meet local communities' healthcare needs and priorities. Building on the success of last year's event, we are excited to host Best of ASCO in Qatar once again, taking place on 26 and 27 September 2025, at Marsa Malaz Kempinski, The Pearl - Doha.

Our comprehensive program covers various topics related to multiple types of cancer, ranging from the most prevalent to the rarest. The agenda has been designed to reflect Qatar's specific cancer care landscape, ensuring the content is relevant and transformative for our attendees. We invite all Clinical Oncology and Cancer Care professionals to join this vital event, which promises invaluable opportunities to learn about the latest developments in the field, network with fellow practitioners, and explore innovative strategies to enhance patient care.

At Best of ASCO 2025, we aim to empower Hamad Medical Corporation (HMC) cancer professionals by enabling them to identify and evaluate cutting-edge research on common tumors, such as breast, colon, lung, and prostate cancers. We will discuss the implications of these findings for treatment options, ensuring that the latest evidence informs our practices.

Moreover, we recognize the importance of rare cancers. The program includes sessions that examine the latest research in their care and management, including those affecting the neurological, head and neck, urological, gynecological, and sarcoma domains. This focus aims to inform attendees about the best practices that can improve patient outcomes across diverse cancer types. Attendees will also be able to assess the implications of advances in emerging therapeutic strategies, including immunotherapy, molecular precision medicine, and tumor biology. These are crucial for both practice and research initiatives within HMC.

In addition, the conference will delve into the latest approaches in symptom management and survivorship. We intend to develop and enhance cancer services within our healthcare system by fostering discussions around these topics.

As we gather for Best of ASCO 2025 in Qatar, we look forward to your participation. Together, we can advance oncology practices and enhance our community's quality of cancer care.

Best regards,